My Background and Focus

Suzanne is a Senior Patent Agent with MBM’s Patent team, responsible for drafting and prosecution of chemical, biochemical, pharmaceutical, as well as cleantech and green technology patents. In addition, Suzanne has extensive expertise in Patented Medicines (Notice of Compliance) Regulations, particularly on issues relating to the timing of information and drug submission requirements for listing a patent on the Patent Register.

Upon completion of her doctoral studies at the University of Alberta, Suzanne spent two years as a Visiting Fellow at the Steacie Institute for Molecular Sciences at the National Research Council of Canada before beginning her patent law career at MBM in 2002.

She has a broad research background, including practical experience in oligosaccharide synthesis (both chemical and enzymatic), synthetic organic chemistry (including solid-phase synthetic methods), as well as various biochemical and analytical methods. Suzanne’s doctoral thesis focused on the synthesis of GM1 analogues, and it investigated the binding of these analogues to cholera and heat-labile enterotoxins.

Suzanne is a Registered Canadian Patent Agent.